| Date Filed | Type | Description |
| 08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/31/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/23/2023 |
SC 13D
| Black Robe Capital LLC reports a 15.7% stake in INHIBITOR THERAPUTICS, INC. |
| 05/23/2023 |
SC 13G
| TPB 2012 LLC reports a 16.4% stake in Inhibitor Therapeutics, Inc. |
| 05/17/2023 |
4
| MCNULTY JAMES A (See Remarks) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Disposed of 79,627,069 shares
@ $0
Acquired 398,135 shares
@ $0
Acquired 20,101,057 shares
@ $0 |
|
| 05/17/2023 |
3
| Black Robe Capital LLC (10% Owner) has filed a Form 3 on Inhibitor Therapeutics, Inc. |
| 05/17/2023 |
4
| Yanez Michelle (Director) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Acquired 796,271 shares
@ $0 |
|
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 12/22/2022 |
3
| SEARS SAMUEL P JR (Director) has filed a Form 3 on Inhibitor Therapeutics, Inc. |
| 12/22/2022 |
3
| Vasisht Niraj (Director) has filed a Form 3 on Inhibitor Therapeutics, Inc. |
| 12/22/2022 |
3
| Yanez Michelle (Director) has filed a Form 3 on Inhibitor Therapeutics, Inc. |
| 12/22/2022 |
3
| ODONNELL FRANCIS E JR (See Remarks) has filed a Form 3 on Inhibitor Therapeutics, Inc. |
| 12/22/2022 |
3
| MCNULTY JAMES A (See Remarks) has filed a Form 3 on Inhibitor Therapeutics, Inc. |
| 12/19/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 09/15/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 06/03/2022 |
8-K
| Quarterly results |
| 05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 03/30/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 01/18/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 11/12/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/13/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 05/14/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 03/26/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 01/19/2021 |
4
| Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Acquired 2,240,488 shares
@ $0 |
|
| 01/06/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/28/2020 |
4
| Hasara Garrison J. (CFO and Treasurer) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 125,000 options
@ $0.031, valued at
$3.9k
|
|
| 12/28/2020 |
4
| Watson W. Mark (Director) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 1,306,452 options
@ $0.031, valued at
$40.5k
|
|
| 12/28/2020 |
4
| Ono Richard Dana (Director) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 754,839 options
@ $0.031, valued at
$23.4k
|
|
| 12/28/2020 |
4
| Peattie Debra (Director) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 580,646 options
@ $0.031, valued at
$18k
|
|
| 12/28/2020 |
4
| VIRCA NICHOLAS J (President and CEO) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 125,000 options
@ $0.031, valued at
$3.9k
|
|
| 12/28/2020 |
4
| Martin Robert Daniel (Director) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 754,839 options
@ $0.031, valued at
$23.4k
|
|
|